Skip to content

Unidoc Health Seeks $1.5M Funding to Revive Telemedicine Ambitions

After a rocky summer, Unidoc Health is fighting to turn its fortunes around. A successful $1.5M funding round could help the company deliver on its telemedicine promises.

In this picture it looks like a pamphlet of a company with an image of a cup on it.
In this picture it looks like a pamphlet of a company with an image of a cup on it.

Unidoc Health Seeks $1.5M Funding to Revive Telemedicine Ambitions

Unidoc Health, a Canadian eHealth company, has been facing a series of challenges. In August, the company's shares were halted due to missing annual reports. Now, it's seeking to raise $1.5 million through a funding round, aiming to regain investor trust and develop telemedical solutions.

The trading halt in August was a significant setback for Unidoc Health. However, the company has since resumed trading at the end of the same month. A recent analyst report from October 4 suggests a cautious but possible reintroduction to trading, despite uncertainties and potential regulatory hurdles.

Unidoc Health is launching a $1.5 million funding round, issuing up to 10 million new shares at $0.15 each, a 25% premium over the current price. The funds will be used to develop telemedical solutions in the form of kiosks for remote consultations, a move that could help the company tap into the rapidly growing global telemedicine market.

Investors in the funding round will also receive warrants, allowing them to purchase further shares at $0.25 each. The company urgently needs these funds for inventory, marketing, and general business activities, with the money expected to flow by October 15th, pending approval from the Canadian Securities Exchange. The next test for Unidoc Health comes in November with the release of its quarterly report, which will show whether the fresh funds are bringing progress in marketing its H3 Health Cubes.

Unidoc Health's future hangs in the balance as it fights for survival. The success of its $1.5 million funding round and the progress shown in its November quarterly report will be crucial in determining whether the company can turn its fortunes around and capitalize on the growing telemedicine market.

Read also:

Latest